Impact of Transcatheter Tricuspid Valve Repair on Pre- and Post-Procedural Hospitalization Rates

The effectiveness of tricuspid transcatheter edge-to-edge repair (TEER) in reducing heart failure (HF) hospitalizations is unclear. Using Medicare and Medicaid data (2015-2019), 487 patients undergoing isolated tricuspid TEER (n = 258) or concomitant tricuspid and mitral TEER (n = 229) were identified. HF hospitalization rates were compared across 4 time periods (in days: 1-30, 31-90, 91-182, 183-365) using Poisson regression. Patients (median age: 80 years) had fewer HF hospitalizations after tricuspid TEER (adjusted rate ratio 0.55, 95% confidence interval: 0.43-0.70, P < 0.001) and when separated by concomitant tricuspid and mitral TEER (adjusted rate ratio 0.57, 95% confidence interval: 0.42-0.79, P < 0.001). In real-world analysis, tricuspid-TEER is associated with a reduced HF hospitalization rate.